COMMUNIQUÉS West-GlobeNewswire

Corbus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
NORWOOD, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical-stage company focused on new therapies in oncology and obesity, today announced the grant of inducement [...]
Bridging Healthcare and Football: How Ballipinar Dental Clinic is Scoring Big in the UK Market
17/08/2026
CEO of Antalya-based dental healthcare provider Ballipinar Dental Clinic Rıdvan Ballipinar talks about how they created international visibility and connections through their partnership with English football club [...]
DentSpa Earns GHA Certification for Its International Patient Experience
17/08/2026
Global Healthcare Accreditation (GHA) recognizes DentSpa’s systems to support patients before their trip, during their treatment in Istanbul and after their return Photo: DentSpa executives with GHA team ISTANBUL, Aug. [...]
Zealand Pharma - Transactions related to share buy-back program (week 33, 2026)
17/08/2026
Company announcement No. 40 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 33, 2026) Copenhagen, Denmark, August 17, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: [...]
Coloplast A/S - Announcement no. 6/2026 - Coloplast announces changes to Executive Leadership Team
17/08/2026
Coloplast announces changes to Executive Leadership Team Today, Coloplast announces two changes to the company’s Executive Leadership Team (ELT). The changes strengthen the leadership of Coloplast’s people & culture [...]
Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
17/08/2026
BOTHELL, Wash., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) ("Cocrystal" or the "Company"), a clinical-stage biotechnology company developing novel therapeutics to meet the growing global [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 33 - 2026
17/08/2026
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 11 août 2026 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code identifiant [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 33 - 2026
17/08/2026
Aggregated presentation by day and by market Weekly report on share repurchases on 11th August 2026 Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily [...]
InspireMD Reports Second Quarter 2026 Financial Results
17/08/2026
- Company to host investor conference call today, August 17 th , at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR) (“InspireMD” or the “Company”), developer of the CGuard ® Prime [...]
Can-Fite: Namodenoson Enhances the Anti-Cancer Effect of Chemotherapy in Pancreatic Cancer
17/08/2026
The New Mechanistic Findings Support Can-Fite’s Ongoing Phase IIb Study Design Following Positive Phase IIa Results Ramat Gan, Israel, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd . (NYSE American: CANF) ( [...]
EyePoint Announces Topline Data from LUGANO, the First of Two Pivotal Phase 3 Clinical Trials for DURAVYU™ 2.7mg in Wet AMD
17/08/2026
– DURAVYU was non-inferior to on-label aflibercept control (nominal p-value = 0.0096) in an ad hoc analysis excluding a 4% asymmetric cohort (9 of 211 patients) who experienced vision loss (≥ 15 letters) unrelated to [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET
17/08/2026
Key recent and second quarter highlights include: Completed first-cycle FDA review of the Company’s ANDA for preservative-free ketamine with no drug-related major deficiencies. The sole remaining item, a manufacturer's [...]
Fulcrum Therapeutics and Slate Medicines Announce Merger Agreement to Advance Next-Generation Migraine Therapies
17/08/2026
Combined company to operate as Slate Medicines and focus on advancing Slate's portfolio of next-generation migraine therapeutics Slate’s lead product candidate, SLTE-1009, is a clinical stage, potentially best-in-class [...]
SEED Therapeutics Nominated for 2026 Prix Galien USA “Best Start-Up” Award
17/08/2026
Second Consecutive Nomination Recognizes SEED’s Progress in Rational Molecular Glue Development and Targeted Protein Degradation Recognition Follows First-in-Human Proof of Mechanism for Lead RBM39 Degrader ST-01156 in [...]
Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026
17/08/2026
Dividend to be Paid Consistent with the Company's Cash Dividend Policy REHOVOT, Israel and HOBOKEN, N.J., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company [...]
Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
17/08/2026
Completed acquisition of Azora Therapeutics, adding AT177, a fully synthetic, oral, colon-targeted aryl hydrocarbon receptor (“Ahr”) agonist in development for ulcerative colitis, to its pipeline Closed initial $32 [...]
Tilray Medical Accelerates the Commercial Expansion of Tilray Medical-Branded Cannabis Medicines in the UK with First Direct-to-Patient Launch Through Lyphe Clinic and Lyphe Dispensary
17/08/2026
Launch connects Tilray Medical’s European cultivation and pharmaceutical manufacturing capabilities with Lyphe Clinic and Lyphe Dispensary to expand direct patient access across the UK and advance Tilray’s integrated [...]
Zelluna receives Independent Data Monitoring Committee recommendation to continue patient enrolment in ZIMA-101
17/08/2026
Independent Data Monitoring Committee (IDMC) recommends recruitment of the next two patients at the first dose level First patient completed the planned first treatment cycle with no serious adverse events or dose- [...]
Montauk Brewing Company Expands Its Coastal Footprint with New North Shore Brewpub
17/08/2026
Beloved Long Island craft beer brand opens its second taproom, bringing fresh brews, beach-town energy and Montauk’s come-as-you-are spirit to Port Jefferson MONTAUK, N.Y., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Montauk [...]

Pages